A Faster Spinning Earth May Cause Timekeepers to Subtract a Second from World Clocks

This image provided by NOAA/NASA In This May 31, 2018 satellite image shows the Earth's western hemisphere at 12:00 p.m. EDT on May 20, 2018, made by the new GOES-17 satellite, using the Advanced Baseline Imager (ABI) instrument. (NOAA/NASA via AP, File)
This image provided by NOAA/NASA In This May 31, 2018 satellite image shows the Earth's western hemisphere at 12:00 p.m. EDT on May 20, 2018, made by the new GOES-17 satellite, using the Advanced Baseline Imager (ABI) instrument. (NOAA/NASA via AP, File)
TT

A Faster Spinning Earth May Cause Timekeepers to Subtract a Second from World Clocks

This image provided by NOAA/NASA In This May 31, 2018 satellite image shows the Earth's western hemisphere at 12:00 p.m. EDT on May 20, 2018, made by the new GOES-17 satellite, using the Advanced Baseline Imager (ABI) instrument. (NOAA/NASA via AP, File)
This image provided by NOAA/NASA In This May 31, 2018 satellite image shows the Earth's western hemisphere at 12:00 p.m. EDT on May 20, 2018, made by the new GOES-17 satellite, using the Advanced Baseline Imager (ABI) instrument. (NOAA/NASA via AP, File)

Earth’s changing spin is threatening to toy with our sense of time, clocks and computerized society in an unprecedented way — but only for a second.

For the first time in history, world timekeepers may have to consider subtracting a second from our clocks in a few years because the planet is rotating a tad faster than it used to. Clocks may have to skip a second — called a "negative leap second" — around 2029, a study in the journal Nature said Wednesday.

"This is an unprecedented situation and a big deal," said study lead author Duncan Agnew, a geophysicist at the Scripps Institution of Oceanography at the University of California, San Diego. "It’s not a huge change in the Earth’s rotation that’s going to lead to some catastrophe or anything, but it is something notable. It’s yet another indication that we’re in a very unusual time."

Ice melting at both of Earth’s poles has been counteracting the planet's burst of speed and is likely to have delayed this global second of reckoning by about three years, Agnew said.

"We are headed toward a negative leap second," said Dennis McCarthy, retired director of time for the US Naval Observatory who wasn’t part of the study. "It’s a matter of when."

It’s a complicated situation that involves, physics, global power politics, climate change, technology and two types of time.

Earth takes about 24 hours to rotate, but the key word is about.

For thousands of years, the Earth has been generally slowing down, with the rate varying from time to time, said Agnew and Judah Levine, a physicist for the time and frequency division of the National Institute of Standards and Technology.

The slowing is mostly caused by the effect of tides, which are caused by the pull of the moon, McCarthy said.

This didn’t matter until atomic clocks were adopted as the official time standard more than 55 years ago. Those didn’t slow.

That established two versions of time — astronomical and atomic — and they didn't match. Astronomical time fell behind atomic time by 2.5 milliseconds every day. That meant the atomic clock would say it’s midnight and to Earth it was midnight a fraction of a second later, Agnew said.

Those daily fractions of seconds added up to whole seconds every few years. Starting in 1972, international timekeepers decided to add a "leap second" in June or December for astronomical time to catch up to the atomic time, called Coordinated Universal Time or UTC. Instead of 11:59 and 59 seconds turning to midnight, there would be another second at 11:59 and 60 seconds. A negative leap second would go from 11:59 and 58 seconds directly to midnight, skipping 11:59:59.

Between 1972 and 2016, 27 separate leap seconds were added as Earth slowed. But the rate of slowing was tapering off.

"In 2016 or 2017 or maybe 2018, the slowdown rate had slowed down to the point that the Earth was actually speeding up," Levine said.

Earth’s speeding up because its hot liquid core — "a large ball of molten fluid" — acts in unpredictable ways, with eddies and flows that vary, Agnew said.

Agnew said the core has been triggering a speedup for about 50 years, but rapid melting of ice at the poles since 1990 masked that effect. Melting ice shifts Earth’s mass from the poles to the bulging center, which slows the rotation much like a spinning ice skater slows when extending their arms out to their sides, he said.

Without the effect of melting ice, Earth would need that negative leap second in 2026 instead of 2029, Agnew calculated.

For decades, astronomers had been keeping universal and astronomical time together with those handy little leap seconds. But computer system operators said those additions aren’t easy for all the precise technology the world now relies on. In 2012, some computer systems mishandled the leap second, causing problems for Reddit, Linux, Qantas Airlines and others, experts said.

"What is the need for this adjustment in time when it causes so many problems?" McCarthy said.

But Russia’s satellite system relies on astronomical time, so eliminating leap seconds would cause them problems, Agnew and McCarthy said. Astronomers and others wanted to keep the system that would add a leap second whenever the difference between atomic and astronomical time neared a second.

In 2022, the world’s timekeepers decided that starting in the 2030s they’d change the standards for inserting or deleting a leap second, making it much less likely.

Tech companies such as Google and Amazon unilaterally instituted their own solutions to the leap second issue by gradually adding fractions of a second over a full day, Levine said.

"The fights are so serious because the stakes are so small," Levine said.

Then add in the "weird" effect of subtracting, not adding a leap second, Agnew said. It’s likely to be tougher to skip a second because software programs are designed to add, not subtract time, McCarthy said.

McCarthy said the trend toward needing a negative leap second is clear, but he thinks it’s more to do with the Earth becoming more round from geologic shifts from the end of the last ice age.

Three other outside scientists said Agnew's study makes sense, calling his evidence compelling.

But Levine doesn’t think a negative leap second will really be needed. He said the overall slowing trend from tides has been around for centuries and continues, but the shorter trends in Earth’s core come and go.

"This is not a process where the past is a good prediction of the future," Levine said. "Anyone who makes a long-term prediction on the future is on very, very shaky ground."



‘Gus’ the T. Rex Fetches Record $50.1 Mn at US Auction

This undated photo provided by Sotheby's on Tuesday, July 14, 2026, shows "Gus," one of the largest and most complete Tyrannosaurus rex specimens ever discovered. (Matthew Sherman/Sotheby's via AP)
This undated photo provided by Sotheby's on Tuesday, July 14, 2026, shows "Gus," one of the largest and most complete Tyrannosaurus rex specimens ever discovered. (Matthew Sherman/Sotheby's via AP)
TT

‘Gus’ the T. Rex Fetches Record $50.1 Mn at US Auction

This undated photo provided by Sotheby's on Tuesday, July 14, 2026, shows "Gus," one of the largest and most complete Tyrannosaurus rex specimens ever discovered. (Matthew Sherman/Sotheby's via AP)
This undated photo provided by Sotheby's on Tuesday, July 14, 2026, shows "Gus," one of the largest and most complete Tyrannosaurus rex specimens ever discovered. (Matthew Sherman/Sotheby's via AP)

A Tyrannosaurus rex skeleton nicknamed "Gus" sold Tuesday for $50.1 million at Sotheby's in New York, making it the most valuable dinosaur fossil bought at auction after a 10-minute battle between seven bidders.

"Gus" is one of the world's most complete T. rex skeletons -- with 183 fossilized bones -- and was discovered on a cattle ranch in South Dakota in 2021.

The giant beast lived some 72 to 66 million years ago -- a period characterized by a warm climate, high sea levels and vast floodable coastal plains.

The skeleton measures 38 feet (11.6 meters) in body length, making it one of the largest T. rexes ever discovered. It is roughly 63 percent complete.

Tuesday's purchase by an anonymous buyer highlights a surging market for dinosaur bones -- a trend that has drawn criticism from some paleontologists over the specimens going into private hands.

"The United States is the only country in the world where fossils like this are considered personal property," Cassandra Hatton, head of science and natural history at Sotheby's, told AFP before the auction.

"If you own the land, you own the fossil and you have the right to sell it. So if you want a dinosaur, this is the only place that you can get it," she said.

The previous record for a fossil auction was "Apex" the Stegosaurus, bought for $44.6 million in 2024 by hedge fund billionaire Ken Griffin.


An Experimental Alzheimer’s Drug Shows Promise Targeting a Different Brain Protein, New Study Shows

 These brain scan images provided by Biogen show how high levels of Alzheimer's-related tau protein, in red, dropped in a recipient of the company's experimental drug diranersen. (Biogen via AP)
These brain scan images provided by Biogen show how high levels of Alzheimer's-related tau protein, in red, dropped in a recipient of the company's experimental drug diranersen. (Biogen via AP)
TT

An Experimental Alzheimer’s Drug Shows Promise Targeting a Different Brain Protein, New Study Shows

 These brain scan images provided by Biogen show how high levels of Alzheimer's-related tau protein, in red, dropped in a recipient of the company's experimental drug diranersen. (Biogen via AP)
These brain scan images provided by Biogen show how high levels of Alzheimer's-related tau protein, in red, dropped in a recipient of the company's experimental drug diranersen. (Biogen via AP)

An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday.

Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can target the protein have failed. Two Alzheimer’s drugs, lecanemab and donanemab, try to clear buildup of the better-known amyloid protein and can modestly slow cognitive decline.

The new findings suggest Biogen's diranersen did more than lower tau levels. The study of about 400 people found signs that it also slowed cognitive decline, in one small subset enough to be comparable to amyloid therapy, according to results presented at the Alzheimer's Association International Conference in London. Biogen is planning a larger study to try to prove the drug’s benefit.

“This is really quite promising if it were to hold up” in that next-step testing, said Jessica Langbaum of the Banner Alzheimer’s Institute in Phoenix, who wasn’t involved with Biogen’s study.

“This is early days,” cautioned Dr. Reisa Sperling of Mass General Brigham, who also wasn’t involved in the study. But “I think it will reinvigorate interest and investment in lots of tau mechanisms, and the field needs that.”

It’s one of multiple novel attempts to fight the mind-destroying disease, including a possible tau vaccine, an experimental heart drug that might do double-duty for some people at high risk of Alzheimer's, and ways to help medicines more easily get across the so-called blood-brain barrier.

It’s not clear exactly what causes Alzheimer’s, which affects more than 7 million Americans and tens of millions worldwide. That sticky amyloid protein starts building up to form plaques in the brain about two decades before symptoms appear. But amyloid alone isn’t enough to cause Alzheimer's.

Many scientists believe that amyloid buildup eventually triggers an abnormal form of tau to form tangles in neurons, setting off symptoms.

Diranersen is what’s called an antisense oligonucleotide that doesn't attack tau buildup but instead instructs a tau-producing gene to produce less.

“If you lower tau production, you are lowering the amount of the abnormal tau that needs to be cleared by the microglia, by the clearance mechanism in the brain. And so, you are enabling the normal clearance mechanism to have more capacity to clear the tau,” said Dr. Cath Mummery of University College London, who led the new study.

Today’s anti-amyloid drugs are given through the bloodstream via infusions or injections. Diranersen is injected into the fluid surrounding the spinal cord, a straighter path to the brain.

Biogen's tau drug missed a key study goal — but was still encouraging Biogen’s study included people with mild cognitive impairment or mild Alzheimer’s, randomly assigning them to different doses of diranersen or a placebo.

Back in May, Biogen and partner Ionis Pharmaceuticals announced that the lowest dose — given every six months — had the strongest effect. That was a counterintuitive surprise and meant the study didn't meet its planned goal of showing that higher doses brought greater benefits.

Still, scientists had been anxiously awaiting details about how much that twice-a-year spinal shot really helped. Five of six different brain tests showed diranersen recipients’ memory and other cognitive abilities still worsened but more slowly than those given dummy shots, Mummery said.

In one test of the lowest dose, that translated to a 26% reduction in cognitive decline — “approximately the same” change seen in earlier tests of amyloid drugs, she said.

Side effects included injection site pain and a temporary state of confusion that could appear a few days after the shot and last about a week, she said. But there were no signs of brain inflammation, which can affect recipients of anti-amyloid drugs.

Alzheimer's researchers also target tau in a broad new study

The University of California, San Francisco, last week opened a first-of-its-kind study known as the Alzheimer’s Tau Platform.

Funded by the National Institutes of Health, it will test a variety of experimental anti-tau therapies against and in combination with today’s amyloid treatments. First up is a vaccine called AADvac1 designed to train the immune system to recognize and fight a specific worrisome portion of the tau protein, said UCSF's Dr. Adam Boxer.

The “platform” approach will expand to locations around the country, allow addition of other tau drugs to test and include people with Alzheimer’s-related protein buildup who aren’t yet showing symptoms, he said.

Other studies hint at new ways of attacking Alzheimer's

Researchers told the Alzheimer’s meeting that an experimental cholesterol-lowering drug called obicetrapib might do more than help heart health. They're exploring if it also might lower buildup of Alzheimer's-related proteins in people who carry a genetic risk for the disease.

Why? That gene, called APOE4, also affects how the body processes cholesterol. Obicetrapib maker NewAmsterdam Pharma plans to begin a study soon to test if the drug's cholesterol effects also can mitigate the Alzheimer's risk in people carrying one or two copies of that gene.

Companies also are trying to get Alzheimer’s drugs into the brain faster and at higher volumes, by penetrating the protective lining meant to protect the brain from harm.

Denali Therapeutics' CEO Ryan Watts describes it as “hitching a ride” with iron that naturally gets into the brain. His company is pursuing drugs that target tau and amyloid using that “transport vehicle” technology.


A US-Russian Space Crew Launches on a Mission to the International Space Station

The Soyuz rocket is rolled out by train to the launch pad, Saturday, July 11, 2026, at Site 31 of the Baikonur Cosmodrome in Kazakhstan. (Bill Ingalls/NASA via AP)
The Soyuz rocket is rolled out by train to the launch pad, Saturday, July 11, 2026, at Site 31 of the Baikonur Cosmodrome in Kazakhstan. (Bill Ingalls/NASA via AP)
TT

A US-Russian Space Crew Launches on a Mission to the International Space Station

The Soyuz rocket is rolled out by train to the launch pad, Saturday, July 11, 2026, at Site 31 of the Baikonur Cosmodrome in Kazakhstan. (Bill Ingalls/NASA via AP)
The Soyuz rocket is rolled out by train to the launch pad, Saturday, July 11, 2026, at Site 31 of the Baikonur Cosmodrome in Kazakhstan. (Bill Ingalls/NASA via AP)

A US-Russian space crew blasted off successfully Tuesday on a mission to the International Space Station.

NASA astronaut Anil Menon and Russian crewmates Pyotr Dubrov and Anna Kikina lifted off from the Russia-leased Baikonur cosmodrome in Kazakhstan aboard the Roscosmos Soyuz MS-29 for an eight-month stint on the orbiting outpost. They are set to dock at the station three hours after the launch, The AP news reported.

Isaacman ’s trip to the Russia-leased Baikonur cosmodrome in Kazakhstan marked the first visit by a NASA chief in eight years.

Speaking during Monday’s meeting with the crew, Isaacman thanked Russia's state space corporation, Roscosmos, for its efforts to prepare for the mission, saying that “the integrated work performed over the past several months reflects the professionalism and dedication of everyone involved.”

Isaacman also met with Roscosmos head Dmitry Bakanov before the launch of NASA astronaut Anil Menon and Russian crewmates Pyotr Dubrov and Anna Kikina. They were set to blast off aboard the Roscosmos Soyuz MS-29 for an eight-month stint on the International Space Station.

The mission is Menon’s first space flight and the second for Dubrov and Kikina.

The trio will join NASA astronauts Jessica Meir, Jack Hathaway and Chris Williams, European Space Agency astronaut Sophie Adenot and Roscosmos cosmonauts Sergei Kud-Sverchkov, Sergei Mikaev and Andrei Fedyaev.

Once bitter rivals in the space race during the Cold War, Russia and the US cooperate on the space station and other projects. That relationship was marred by tensions after Moscow sent troops into Ukraine in 2022, but Washington and Moscow have continued to work together, with US and Russian crews flying to the orbiting outpost on each country’s spacecraft.

Plans for broader cooperation, including possible Russian involvement in NASA’s Artemis program of lunar research, have fallen apart. As Russia has become increasingly reliant on China for its energy exports and imports of key technology amid Western sanctions, Roscosmos has started cooperation with China on its prospective lunar mission.